Kidney Week to Open with Groundbreaking COVID-19 Panel

Full access

Anthony Fauci, MD

Citation: Kidney News 13, 10/11


Sanjay Gupta, MD

Citation: Kidney News 13, 10/11

ASN is partnering with the National Academy of Medicine to kick off Kidney Week with a first-of-its-kind opening plenary presenting a COVID-19 update, with a global focus on kidney health.

Anthony Fauci, MD, will present the keynote address on “Public Health Lessons Learned and Implications for Future Pandemics.”

The moderator will be the well-known CNN chief medical correspondent Sanjay Gupta, MD.

The plenary speakers will highlight the viral pathogenesis and importance of the COVID-19 variants in the development of next-generation therapies and vaccines and provide expert opinions on public health policy and the potential long-term impact on cardiovascular and kidney health.

Perhaps the highest profile career official in the federal response to COVID-19, Dr. Fauci has been director of the National Institute of Allergy and Infectious Diseases since 1984, where he oversees an extensive research portfolio focused on infectious and immune-mediated diseases. As the long-time chief of the institute's laboratory of immunoregulation, he has made many seminal contributions in basic and clinical research and is one of the world's most-cited biomedical scientists.

Dr. Gupta is a practicing neurosurgeon who has won multiple Emmy awards for his work reporting on health and medical news for all of CNN's programs domestically and internationally. He has covered some of the most important health stories in the United States and around the world since 2001.


Amitava Banerjee, MD, MPH, DPhil

Citation: Kidney News 13, 10/11


Ashish K. Jha, MD, MPH

Citation: Kidney News 13, 10/11


Jeffrey I. Silberzweig, MD

Citation: Kidney News 13, 10/11


Susan R. Weiss, PhD

Citation: Kidney News 13, 10/11

They will be joined on the panel by the following four other experts:

  • Amitava Banerjee, MD, MPH, DPhil, is professor of clinical data science at University College London and honorary consultant cardiologist at University College London Hospitals and Barts Health National Health Service Trusts. He is a researcher, educator, and practicing clinician whose interests span health informatics, learning health systems, cardiovascular epidemiology, global health, and evidence-based healthcare. His expertise in epidemiology, biostatistics, public health, and cardiovascular medicine has led to collaborations across traditional disciplines.

  • Ashish K. Jha, MD, MPH, is the dean of the school of public health at Brown University. He is recognized globally as an expert on pandemic preparedness and response. He has led groundbreaking research around the Ebola virus and has worked on the frontlines of the COVID-19 response, leading national and international analyses of key issues and advising state and federal policymakers.

  • Jeffrey I. Silberzweig, MD, is the medical director of the dialysis units at New York-Presbyterian's Weill Cornell and Lower Manhattan Hospitals and the chief medical officer of The Rogosin Institute. He is associate professor of clinical medicine at Weill Cornell Medical College, where he is associate director of the internal medicine residency and nephrology fellowship programs. He has co-chaired the ASN Emergency Partnership Initiative since 2019. When ASN formed its COVID-19 Response Team in the early days of the pandemic, Dr. Silberzweig took on the challenge of serving as co-chair and as chair of its outpatient dialysis subcommittee.

  • Susan R. Weiss, PhD, is professor and vice chair of the Department of Microbiology at the University of Pennsylvania Perelman School of Medicine. She is also co-director of the Penn Center for Research on Coronaviruses and Other Emerging Pathogens. During her long career, she has worked on many aspects of coronavirus replication and pathogenesis, making contributions to understanding the basic biology as well as organ tropism and virulence. For the past 10 years, her work has focused on coronavirus interaction with the host immune response and viral antagonists of double-stranded RNA-induced antiviral pathways.